Prot# P10-023: A 10-Year, Post-Marketing, Observational, Registry of HUMIRA (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (Ps)

Project: Research project

Project Details

StatusFinished
Effective start/end date4/20/09 → 12/31/21

Funding

  • United BioSource LLC (P10-023 // P10-023)
  • Abbott Laboratories (P10-023 // P10-023)